Also listed on G and L Consulting LLC, which filed it. The recorded assignments below show how it moved.
Term ends Nov 7, 2028
Statutory term ends Sep 25, 2027
Base term plus 409 days of PTA
Today
20y-from-earliest-nonprovisional
Expires Nov 2028
2007
2028
Clock starts
Sep 25, 2007
Sep 25, 2007
Granted
Jan 11, 2011
Jan 11, 2011
Term ends
Nov 7, 2028
Nov 7, 2028
base term
patent term adjustment
fee events
Computed Sep 1, 2026 · countdowns run from that date · how we know
409
Days of PTA
1
Applications in this family
This patent's term runs 409 days past the statutory base term on prosecution delay. All three maintenance fees are paid, so nothing but the term itself will end it. Confidence: High. from the record
How this date was computed
Every step shows its rule, its input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20y-from-earliest-nonprovisional | Clock starts Sep 25, 2007 | Sep 25, 2027 | High |
| Continuity chain | Every parent in the chain resolved | no change | High |
| Patent term adjustment | +409 days, USPTO PTA record | Nov 7, 2028 | High |
| Terminal disclaimer cap | None on record | no cap applied | High |
| Patent term extension | None on file | no change | High |
| Fee events | 3 of 3 maintenance fees paid | in-force | High |
| Computed term end | The steps above, in order | Nov 7, 2028 | High |
The computation, verbatim
base=20y-from-earliest-nonprovisional: 2007-09-25+20y | =2027-09-25 | PTA+409d=2028-11-07 | PTE:none | TD:none | paid 4yr@2014-07-07,8yr@2018-07-10,12yr@2022-07-11 | status=in-force@2028-11-07
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 2, 2007 reel/frame not recorded | Levin, Howard; Gelfand, Mark | G&l Consulting, LLC | Assignment of Assignor's Interest |
| Dec 23, 2011 reel/frame not recorded | G&l Consulting, LLC | Backbeat Medical, Inc. | Assignment of Assignor's Interest |
| Feb 13, 2020 reel/frame not recorded | Backbeat Medical, Inc. | Backbeat Medical, LLC | Entity Conversion |
| Jun 6, 2022 reel/frame not recorded | Accelerated Technologies, Inc.; Backbeat Medical, LLC; Caliber Therapeutics, LLC; Freehold Surgical, LLC; Orchestra Biomed, Inc. | Avenue Venture Opportunities Fund, L.P., as Agent | Security Agreement |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Orchestra Biomed, Inc. | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Caliber Therapeutics, LLC | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Backbeat Medical, LLC | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Freehold Surgical, LLC | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Accelerated Technologies, Inc. | Release of Ip Security Interest |
| Nov 6, 2024 reel/frame not recorded | Backbeat Medical, LLC; Caliber Therapeutics, LLC; Freehold Surgical, LLC; Orchestra Biomed Holdings, Inc.; Orchestra Biomed, Inc. | Hercules Capital, Inc. | Security Interest |
| Aug 4, 2025 reel/frame not recorded | Backbeat Medical, LLC; Caliber Therapeutics, LLC; Orchestra Biomed Holdings, Inc.; Orchestra Biomed, Inc. | Ligand Pharmaceuticals, Inc. | Security Interest |
| Aug 7, 2025 reel/frame not recorded | Backbeat Medical, LLC; Caliber Therapeutics, LLC; Orchestra Biomed Holdings, Inc.; Orchestra Biomed, Inc. | Medtronic, Inc. | Security Interest |
Free plan: 3 watched companies. Pro: unlimited.
alerts on grants, lapses, transfers
Is this your company? Verify this record
What's changing
Nov 2028
Term ends. No further fees fall due before then
Note
The 409 days of PTA are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.